Sciele Pharma and Plethora Solutions Announce Positive Phase III … – Business Wire (press release)
Business Wire (press release) |
Sciele Pharma and Plethora Solutions Announce Positive Phase III …
Business Wire (press release), CA - Nov 7, 2008 There are currently no approved pharmaceutical treatments for premature ejaculation. PSD502 is applied locally "on demand" and is effective within five … Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK all 14 news articles |
